myTomorrows

Home
myTomorrows

myTomorrows is an international platform that links patients facing unmet medical needs to treatments in development worldwide.

We bridge the gap between patients who are searching for treatment options and the pharmaceutical companies who provide them At myTomorrows, we believe everyone should be able to access the treatment options which are open to them. We strive to make it easier for physicians and their patients with unmet medical needs to find, get information about, and access pre-approval medicines whenever possible. We believe that by making the process of accessing pre-approval medicines more transparent, we’ll be able to transform the lives of people all over the world. To contact us, please visit https://www.mytomorrows.com/en/get-in-contact.

28/02/2026

Today, on Rare Disease Awareness Day, we are taking a closer look at what “rare” really means.

A disease is considered “rare” when it affects fewer than 1 in 2,000 people. Yet, with more than 7,000-8,000 identified rare diseases, they collectively impact over 300 million people worldwide – a reality we can’t overlook.🌍

And behind every number is a person. A family. A story.
An experience shaped by resilience, uncertainty, hope, and strength.

Over the years, we’ve supported thousands of people navigating rare diseases, including more than 7,000 individuals affected by Duchenne muscular dystrophy.

These aren’t just statistics for us. They represent conversations, questions, and courage.

For us at myTomorrows, understanding what it means to live with a rare disease is recognizing that no two journeys are the same. Yet together, as a community, we can drive progress forward.

For us, rare means unique - but never alone. ♥️

This week, our team came together to show our support in a special way. Each of us dipped our hands into different colors of paint and added our handprint to a canvas.

This serves as a reminder that:

🎨 Every experience is different
💙 Every story matters
🤝 Progress happens when we move forward together

📸 Below are a few snapshots of the handprints we left behind: our way of expressing our long-term commitment to raising awareness, supporting advances in care, and working toward a more equitable future for the rare disease community.

At myTomorrows, we understand that every person’s experience with a rare disease is unique. That’s why our Patient Navigators offer personalized support and clear, practical information to people and families exploring clinical trial opportunities.

Because every journey deserves to be seen, supported, and understood.

26/02/2026

Next week, we’re heading to Save Our Sites for the very first time! 🚀

We’re excited to be part of this forward-looking community that’s working hard to strengthen site partnerships and drive research forward.

Our team is eager to meet Sites, Biopharma teams, and CRO partners who share the same view on accelerating access to clinical trials.

This is a great opportunity for us to learn from the field, hear what’s working, and understand where support is still needed.

👉 Come talk to us at Booth 15 to learn how we’re helping remove barriers and make trial enrollment easier for both patients and sites.

If you’re attending, we’d love to meet you, swap insights, and explore new ways to collaborate.

See you in San Diego next week.

24/02/2026

⏱️ Clinical trial recruitment remains one of the most resource-intensive challenges sites face.

Even with dedicated teams, enrollment is often slowed by fragmented referral pathways, manual pre-screening, and repeated follow-up across siloed systems.

That’s why gatherings like the SCRS European Site Solutions Summit matter - not as routine industry touchpoints, but as spaces to focus on what sites truly need to make recruitment more feasible.

At myTomorrows, we partner with sites globally to enable smarter, more sustainable recruitment pathways through:

☑️ A centralized referral platform connecting sites, sponsors, physicians, and patients in one seamless workflow
☑️ AI-supported pre-screening to streamline eligibility checks and reduce coordinator burden and eventually increase screen success-rates.
☑️ Hands-on patient navigation to support recruitment, retention, and avoid preventable drop-offs
☑️ Compliance-first, site-optimized workflows built for clinical research teams

📍 We’ll be in Amsterdam on 2–3 March 2026, and we’d love to meet you in person. Stop by booth #30 to connect with:

🔹Mar Soto Ruiz de la Torre, PhD, Commercial Strategy & Operations Lead
🔹Adrianne Rivard, Senior Community Development Manager
🔹Miriam Schaefer-Sharp, Medical Community Operations Specialist

If you’re looking to strengthen recruitment capabilities at your site while reducing operational burden, let’s connect.

Tot volgende week in Amsterdam!

19/02/2026

🔐 Introducing the myTomorrows Trust Center: Security, Compliance & Transparency

At myTomorrows, trust is fundamental to everything we do.

Working at the intersection of healthcare, clinical research, and patient access means handling highly sensitive clinical and patient data - and protecting it is a responsibility we take seriously.

That’s why we’re proud to announce the launch of the myTomorrows Trust Center: a centralized space where partners and clinical trial sites can easily access our security, compliance, and assurance documentation.

With experience supporting 50+ pharmaceutical companies, 444+ clinical trial sites, and over 3,000 physicians, we understand what trusted collaboration requires.

The Trust Center provides transparent, centralized access to:
✅ Key certifications like ISO 27001 and SOC 2 Type II
✅ Security and privacy practices protecting sensitive clinical data
✅ Risk management, incident response, and business continuity information
✅ Assurance reports and third-party transparency

💬 “We’re proud of the security and compliance standards we’ve achieved at myTomorrows. The Trust Center is an important step in making that commitment transparent, giving our valued partners clear, trusted evidence of how we protect sensitive data.”- Filippo Mandrini, Senior Security Officer

The goal is simple:
🔹streamline due diligence
🔹 reduce back-and-forth during onboarding
🔹 provide confidence in how we manage risk, security, and compliance

👉 Read more about our commitment to security, transparency, and trusted collaboration: https://eu1.hubs.ly/H0rY4CY0
🔗 Explore the myTomorrows Trust Center here: https://eu1.hubs.ly/H0rY5Bl0

18/02/2026

We’re joining the IMPACCT Real World Evidence Summit Europe in our home city, Amsterdam, next week 🇳🇱
Looking forward to discussing how real-world data from expanded access programs can strengthen evidence generation in serious and life-threatening diseases.

At myTomorrows, we support BioPharma in designing, operationalizing, and analyzing real-world data collection within expanded access programs. Through our myTomorrows platform, with fit-for-purpose EDC capabilities, we enable structured RWD collection that is operationally feasible, scientifically robust, and compliant in real-world care settings.

🎤 In our session “Real-World Data in Expanded Access: An Integral Part of Evidence Generation”, Nicola Laschi (Director of Pharma Partnerships) and Melissa Ertman (Real-World Data Associate) will discuss key learnings from our experience implementing RWD collection within expanded access programs globally.

📅 February 25th
⏰ 14:30 – 15:00

The session will dive into:
🔹Insights into the practical application of RWD from EAPs.
🔹Misconceptions and best practices in study set-up and design.
🔹Effective management of RWD collection within EAPs to achieve operational excellence.

👉 If you’ll be in Amsterdam for IMPACCT, we’d love to connect.
You can also book a meeting with us: https://eu1.hubs.ly/H0rTb1J0

16/02/2026

That’s a wrap on the 8th TREAT‑NMD International Conference in Lisbon.🇵🇹 We are grateful for the outstanding speakers and deeply thoughtful sessions that made this week so meaningful.

It was great to see so many discussions around patient journeys, trial design and equity, including Expanded Access that were honest and grounded.

Thank you to organizers and everyone who shared their insights, stories, and views on science. Your contributions are shaping a more compassionate and practical path forward for NMD families.

Onward.🚀

16/02/2026

Are you searching for a role at a company with an important mission? 🌍

Our founder started myTomorrows when he couldn’t find a clinical trial for his dad (who was diagnosed with cancer) in time to help him.

We are a purpose-led company looking for people with endless ambition and an entrepreneurial mindset to come innovate with us.

As a fast-growing startup in Amsterdam with 80+ people, we have 30+ nationalities and many great benefits, like a learning budget, flexible working, and a performance bonus just to name a few.

Join us:
📐 Learn in an ever-evolving, dynamic environment.
🤝 Build up your skills in the healthcare sector.
💚 Know that you’re helping patients worldwide.

We're looking for:
✔️Vendor Manager: https://eu1.hubs.ly/H0rNp0P0
✔️Finance Business Partner: https://eu1.hubs.ly/H0rNqpv0
✔️Data Engineer: https://eu1.hubs.ly/H0rNrnR0

👉 Our full list: https://eu1.hubs.ly/H0rNpcM0

12/02/2026

As Valentine’s Day approaches, we’re sharing a little extra love at myTomorrows ♥️

Today, our Mighties at the office took a break to decorate Valentine’s cards, add heart-shaped notes to the ‘Share the Love’ board, and leave thoughtful compliments for one another.

Glitter, kind words, and creativity quickly filled the space, reminding us how small gestures can make a big difference. Roses added a special touch, bringing small moments of joy and appreciation to the day. ✨

☕ In the afternoon, the celebration continued with a cozy high tea. The office filled with the smell of freshly baked scones as our Mighties enjoyed a well-deserved moment to connect, unwind, and share time together.

Moments like these remind us that celebrating gratitude, connection, and care for one another is what truly brings a team together – and what makes working and growing at myTomorrows so meaningful.

📸 Swipe through to catch a glimpse of the love, laughter, and sweet moments that made the day special

Thank you so much to Sacha for organizing such a fantastic celebration and making the day extra special for everyone! 🌟

05/02/2026

On March 10–11, the 2nd edition of the “Pre-Approval Access to Medicines in APAC conference” returns to Singapore.🌏

The conference brings together stakeholders from biopharma, patient advocacy, policy, and government to exchange practical perspectives on access to locally unauthorized medicines outside of clinical trial settings.

As APAC continues to grow in importance, discussions will focus on how pre-approval access decisions made today can shape longer-term pathways toward sustainable, responsible access across the region, while acknowledging the diversity of regulatory maturity, healthcare infrastructure, and patient needs.

This forum is a critical opportunity for stakeholders to engage in shaping the future of access in APAC, learn from regional and global peers, and contribute to the development of more sustainable models.

➡️ Check out the updated agenda and speaker lineup: https://eu1.hubs.ly/H0rwfBF0

👉 Register here: register: https://eu1.hubs.ly/H0rwftk0

This is a must-attend event for organizations actively navigating pre-approval access in the region.

05/02/2026

We are heading to Treat-NMD International Conference 2026 in Lisbon next week 🇵🇹 - sharing what 8 years of patient navigation in neuromuscular diseases has taught us about who gets into trials, and who doesn't.

At myTomorrows, we support thousands of patients every year.
🔹 Families dealing with diagnostic uncertainty.
🔹 Long drives - 6 hours or more - to reach the nearest site.
🔹 Children whose disease is progressing faster than eligibility windows allow.

These people aren't facing a "recruitment challenge." They are facing a system that wasn't designed with patients in mind.

🎤 In our session " 8 Years of Listening: What Patient Journeys in Neuromuscular Disease Teach Us About Recruitment, Expanded Access, and Equity” on February 12, at 17:10, we will share more about:

☑️ Why families say no to trials: It’s not about willingness.
☑️ How patient navigators see gaps that CROs, sponsors & other stakeholders often miss.
☑️ Where expanded access and real-world data can capture evidence from patients excluded by strict eligibility criteria.

Of course, we can revisit the need for greater awareness, discuss clinical trials, or talk about the urgency of improving enrollment metrics.

But we believe the real work is in building research pathways that truly serve the NMD community, including those who have been systematically left out.

👉 If you are there, stop by booth 12 to meet the team: Dennis Akkaya, Chief Commercial Officer, Adrianne Rivard, Senior Community Development Manager, Romina Dibra, MD, Senior EAP Site Manager, and Terri Ellsworth, Patient Liason.
🔗 You can also book a meeting with us: https://eu1.hubs.ly/H0rvLC-0

We hope to see you in Lisbon - Até já

04/02/2026

When approved treatments are exhausted, time becomes the most precious resource. ⏳

Yet for many patients, especially those living with rare diseases, access to clinical trials or when appropriate, expanded access programs, means navigating fragmented information, unclear eligibility criteria, and slow manual workflows all at times when urgency is highest.

🎙️ Our COO, Vanessa Lemarié, explores that reality in her recent conversation with Karen Jagoda on the Empowered Patient Podcast. In the episode, Vanessa discusses some of the most pressing challenges in today’s clinical trial ecosystem:

🔹Many patients are never informed about clinical trials, let alone about expanded access options when appropriate, limiting awareness for potential care opportunities.
🔹Manual trial-matching is slow and inconsistent, with increased missed eligibility for targeted and biomarker-driven studies.
🔹Lengthy recruitment timelines delay study enrollments and dosing schedules, impacting science progression and evidence generation.
🔹Geography, travel burden, and skewed site locations, disproportionately limit access to rural and underserved communities.

For rare disease patients, these challenges are even more pronounced, as trials are increasingly targeted and eligibility pathways more specific, making access harder to navigate despite growing trial activity.

That’s where technology can make a real difference.

Vanessa shares how myTomorrows AI-powered platform supports physicians pre-screen patient information to assess potential eligibility for clinical trials, and where appropriate, expanded access. This approach helps to:

☑️ Reduce trial-matching time by ~90%, improving timely visibility of relevant options.
☑️ Improve matching accuracy, reducing missed eligibility in targeted and biomarker-driven studies.
☑️ Extend reach beyond traditional trial hubs, by enabling remote pre-screening and earlier eligibility assessment at specialists and community centers.

During Rare Disease Awareness Month, this conversation is a timely reminder that innovation plays a critical role in removing barriers and improving access to clinical research, ensuring no patient is left without options.

🎧 Listen to the full conversation on the Empowered Patient Podcast: https://eu1.hubs.ly/H0rtT6r0

04/02/2026

Cancer affects millions of people worldwide. 🌍
Behind every diagnosis is a person, a family, and a unique story.

World Cancer Day is a moment to recognize those experiences, raise awareness, and mobilize action to address the global cancer epidemic. The 2025–2027 theme, “United by Unique” builds on this by calling for a more people-centered care that sees the person beyond the disease and puts individuals - not just cancer - at the heart of every decision.

People-centered care means:

🤝 Collaboration
Listening to what matters to individuals, acknowledging their concerns with empathy, and empowering them to actively participate in the decision-making process.

💬 Connection
Recognizing the importance of social ties by engaging individuals, families, and communities beyond the clinical setting.

👥 Community
Supporting informed and engaged communities to improve health literacy, self-care, and ensure healthcare systems reflect real-world needs.

At myTomorrows, our people-centered approach focuses on helping patients and caregivers learn more about clinical trial options when standard of care is no longer an option. 💚

Our Patient Navigators work closely with individuals to understand their situation, what trial options may be relevant, support informed conversations with treating physicians, and share clear, practical information to help people better understand clinical research pathways.

Because meaningful cancer care starts with understanding the person behind the diagnosis.

# Oncology

Address

Website

https://myTomorrows.com/

Alerts

Be the first to know and let us send you an email when myTomorrows posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to myTomorrows:

Shortcuts

Want your practice to be the top-listed Clinic?

Country:

City: